Fundz

Fundz Deep Dive

Everything you need to win Synfini — in one platform.

Who to reach, what to say, and why now on Synfini — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Synfini — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Synfini Secures $8.9 Million in Funding to Accelerate Drug Development Using AI.

Jul 07, 202511 months ago

Contract Type

agreement

Menlo ParkBiotechnologyArtificial IntelligencePharmaceutical

Description

Synfini, Inc. has announced an $8.9 million funding expansion led by JSL Health Capital. This additional funding will help accelerate the development of their AI-driven platform that streamlines small molecule drug discovery and synthesis.

Company Information

Company

Synfini

Location

Menlo Park, California, United States

About

Synfini, Inc. is a leader in AI-driven chemistry automation focused on drug discovery. The company leverages innovative technology to streamline the development of small molecules. Synfini aims to enhance the efficiency and reduce costs associated with the drug discovery process through its unique platform. It was spun out from SRI in 2023 and has been gaining traction in the market.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Synfini's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.